Status: Recruiting
Delayed Tolerance Through Mixed Chimerism
This study will examine the safety and effectiveness of a bone marrow transplant after kidney transplant (from either a living or deceased donor). An investigational medication and other treatments will be given prior to and after the transplant to help protect the transplanted kidney from being attacked by the body's immune system
Participants needed: 20
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Massachusetts General HospitalUpdated: Sep 28, 2026Locations: 1
Eligibility criteria
Kidney transplant recipients from either LD or DD, with cryo-preserved HSCs avai... [+19]
ABO blood group-incompatible renal allograft. [+15]